RYBELSUS 14 MG TBL NOB 30

What is the maximum co-payment for RYBELSUS?

If the insurance company contributes, the maximum co-payment is 2 414,66 Kč. The maximum pharmacy price is 2 674,75 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price. If the physician marks increased reimbursement on the prescription, the maximum co-payment is 505,75 Kč.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does RYBELSUS have a counted co-payment set?

Yes, the medicine has a counted co-payment of 2 414,00 Kč. Learn more about the protective limit here.

How much does the insurance company pay for one dispensed reimbursed pack?

260,09 Kč.

Does the insurance company pay a higher amount in some cases?

Yes, increased reimbursement exists. A physician with the required specialization may, under strictly defined conditions, set a second reimbursement of 2 169,00 Kč.

Does the medicine have an indication restriction?

Semaglutid p. o. je hrazen v kombinaci s metforminem a/nebo sulfonylureou nebo v kombinaci s thiazolidindiony u pacientů, u nichž použití maximálních tolerovaných dávek zmíněných léčiv po dobu alespoň 3 měsíců společně s režimovými opatřeními nevedlo k uspokojivé kompenzaci diabetu definované jako hladina HbA1c nižší než 53 mmol/mol. Nedojde-li k prokazatelnému zlepšení kompenzace diabetu o 7 % či vyššímu poklesu hladiny HbA1c při kontrole po 6 měsících léčby, semaglutid není dále hrazen. V kombinaci s inzulinem nejsou léčivé přípravky s obsahem semaglutidu p. o. hrazeny. Z prostředků veřejného zdravotního pojištění je hrazena jedna tableta o síle 3 mg, nebo 7 mg, nebo 14 mg denně.

Rychlý přehled

Dosage form Tablets uncoated
Výdej Ne, lék nelze získat bez receptu.
Úhrada / doplatek / cena Ano, podmínky úhrady (vykazovací limit) ale nebyl stanoven. Maximální doplatek: 2 414,66 Kč. Maximální cena: 2 674,75 Kč.
Kdo může předepsat Prescription is not conditional on a medical specialization.
Složení More information about the composition can be found in the SPC, section 6.1.
Dostupnost / výpadek Ukončeno The latest report from the manufacturer is from 29. 5. 2026. Výroba byla ukončena s platností od 1. 6. 2026. The manufacturer lists medicines with the following code as a potential substitute: 0272612
Kód SÚKL 0249514

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe RYBELSUS?

Prescription is not conditional on a medical specialization.

What is the composition of RYBELSUS?

. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

  • Documents could not be found v lokální importní databázi.

Which medicines are similar to RYBELSUS?

The medicine belongs to ATC group A10BJ06. Název skupiny není v lokální importní databázi dostupný.

Who manufactures RYBELSUS?

Informace o výrobci není dostupná.

Is the medicine in shortage?

The latest report from the manufacturer is from 29. 5. 2026. Production was terminated with effect from 1. 6. 2026. The manufacturer lists medicines with the following code as a potential substitute:

What is the unique code for RYBELSUS?

The medicine has code 0249514. Code details can be found here.

How many packs of RYBELSUS were previously dispensed on prescriptions in Czechia?

Show prescription medicine consumption

How many packs of RYBELSUS were previously dispensed on request forms in Czechia?

Show request-form medicine consumption

Z čeho se skládá maximální cena léku?

The page was last updated on 22. 06. 2026

SIMILAR MEDICINES: